Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPRENORPHINE Cause Central nervous system lesion? 8 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Central nervous system lesion have been filed in association with BUPRENORPHINE (Buprenorphine and Naloxone). This represents 0.0% of all adverse event reports for BUPRENORPHINE.

8
Reports of Central nervous system lesion with BUPRENORPHINE
0.0%
of all BUPRENORPHINE reports
0
Deaths
6
Hospitalizations

How Dangerous Is Central nervous system lesion From BUPRENORPHINE?

Of the 8 reports, 6 (75.0%) required hospitalization.

Is Central nervous system lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPRENORPHINE. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does BUPRENORPHINE Cause?

Drug dependence (16,730) Overdose (13,977) Death (13,604) Toxicity to various agents (10,906) Pain (8,219) Drug withdrawal syndrome (7,149) Emotional distress (6,159) Drug abuse (4,344) Drug ineffective (4,261) Dependence (3,184)

What Other Drugs Cause Central nervous system lesion?

FINGOLIMOD (2,416) DIMETHYL (1,152) INTERFERON BETA-1A (978) NATALIZUMAB (627) DALFAMPRIDINE (561) GLATIRAMER (492) TERIFLUNOMIDE (315) ADALIMUMAB (229) OFATUMUMAB (185) RITUXIMAB (151)

Which BUPRENORPHINE Alternatives Have Lower Central nervous system lesion Risk?

BUPRENORPHINE vs BUPRENORPHINE\NALOXONE BUPRENORPHINE vs BUPROPION BUPRENORPHINE vs BUPROPION HYDROBROMIDE BUPRENORPHINE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPRENORPHINE vs BUPROPION\NALTREXONE

Related Pages

BUPRENORPHINE Full Profile All Central nervous system lesion Reports All Drugs Causing Central nervous system lesion BUPRENORPHINE Demographics